ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

The overexpression of GPX8 is correlated with poor prognosis in GBM patients

Li, Sibo; Jiang, Xudong; Guan, Meicun; Zhang, Yi; Cao, Yanfei*; Zhang, Lina*哈尔滨医科大学; 5
Frontiers in Genetics2022-8-17DOI: 10.3389/fgene.2022.898204
3被引8阅读
引用收藏
分享

摘要

Glutathione peroxidase 8 (GPX8), located in the endoplasmic reticulum, is associated with poor prognosis in several cancers. However, the expression and functions of GPX8 in cancers remain unclear. The purpose of this study was to explore the expression and functions of GPX8 in glioblastoma (GBM). We obtained expression data of GPX8 by accessing the TCGA, CGGA, GEPIA, and TIMER2.0 databases and validated them using western blot and immunohistochemistry. The Kaplan-Meier overall survival curve and Cox regression model were used to evaluate the prognostic value of GPX8 in glioma patients. Gene ontology (GO) and function enrichment analysis were used to investigate the potential function of GPX8 in GBM. Correlation analysis was used to clarify the role of GPX8 in proneural-mesenchymal transition (PMT). We studied the correlation between GPX8 expression and GBM immune infiltration by accessing cBioPortal and TIMER2.0 databases. Here, we demonstrated that GPX8 was significantly upregulated in GBM, and was associated with IDH-wildtype and mesenchymal subtype with poor prognosis. Survival analysis results indicated that GPX8 is an independent prognostic factor for overall survival (OS) in all WHO-grade glioma patients. Through the functional studies, we found that high expression of GPX8 correlated with mesenchymal signature and negatively correlated with proneural signature, indicating that GPX8 might promote PMT in GBM. Finally, based on correlation analysis, we found that the expression of GPX8 was associated with immune infiltration and the IL1/MYD88/IRAK/NF-kappa B pathway in GBM. Our results show that GPX8 is a key factor affecting the prognosis of GBM patients, and its targeting has the potential to provide a novel therapeutic approach.

学科与关键词

关键词
GPX8GBMPMTimmune infiltrationprognosis
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Frontiers in Genetics
发表日期
2022-08-17
卷期
第 13 卷
页码
898204
DOI
10.3389/fgene.2022.898204
期刊等级
3区
成果收录
SCIE
资助标注
Heilongjiang Provincial Nature Science Foundation of China; [LH2021H022]

作者

  • L

    Li, Sibo (第一作者)

    daqing oilfield gen hosp

  • J

    Jiang, Xudong

    daqing oilfield gen hosp

查看全部 6 位作者收起作者
  • G

    Guan, Meicun

    2 · jiamusi univ

  • Z

    Zhang, Yi

    5 · harbin med univ

  • C

    Cao, Yanfei (通讯)

    daqing oilfield gen hosp

  • Z

    Zhang, Lina (通讯)

    harbin med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417